Literature DB >> 29887419

Too sweet to resist: Control of immune cell function by O-GlcNAcylation.

Tristan de Jesus1, Sudhanshu Shukla1, Parameswaran Ramakrishnan2.   

Abstract

O-linked β-N-acetyl glucosamine modification (O-GlcNAcylation) is a dynamic, reversible posttranslational modification of cytoplasmic and nuclear proteins. O-GlcNAcylation depends on nutrient availability and the hexosamine biosynthetic pathway (HBP), which produces the donor substrate UDP-GlcNAc. O-GlcNAcylation is mediated by a single enzyme, O-GlcNAc transferase (OGT), which adds GlcNAc and another enzyme, O-GlcNAcase (OGA), which removes O-GlcNAc from proteins. O-GlcNAcylation controls vital cellular processes including transcription, translation, the cell cycle, metabolism, and cellular stress. Aberrant O-GlcNAcylation has been implicated in various pathologies including Alzheimer's disease, diabetes, obesity, and cancer. Growing evidences indicate that O-GlcNAcylation plays crucial roles in regulating immunity and inflammatory responses, especially under hyperglycemic conditions. This review will highlight the emerging functions of O-GlcNAcylation in mammalian immunity under physiological and various pathological conditions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immunity; Lymphocytes; Macrophages; NF-κB; NFAT; Neutrophils; O-GlcNAcylation; OGA; OGT; Phosphorylation

Mesh:

Substances:

Year:  2018        PMID: 29887419      PMCID: PMC6275141          DOI: 10.1016/j.cellimm.2018.05.010

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  108 in total

1.  Hyper-O-GlcNAcylation activates nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) signaling through interplay with phosphorylation and acetylation.

Authors:  Zhiyuan Ma; Robert J Chalkley; Keith Vosseller
Journal:  J Biol Chem       Date:  2017-04-17       Impact factor: 5.157

Review 2.  Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.

Authors:  Gerald W Hart; Chad Slawson; Genaro Ramirez-Correa; Olof Lagerlof
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

3.  Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia.

Authors:  Y Shi; J Tomic; F Wen; S Shaha; A Bahlo; R Harrison; J W Dennis; R Williams; B J Gross; S Walker; J Zuccolo; J P Deans; G W Hart; D E Spaner
Journal:  Leukemia       Date:  2010-07-29       Impact factor: 11.528

4.  B cell receptor directs the activation of NFAT and NF-kappaB via distinct molecular mechanisms.

Authors:  Pierre Antony; James B Petro; Gianluca Carlesso; Nicholas P Shinners; John Lowe; Wasif N Khan
Journal:  Exp Cell Res       Date:  2003-11-15       Impact factor: 3.905

5.  c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas.

Authors:  T Y Chou; G W Hart; C V Dang
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

6.  Structure of an O-GlcNAc transferase homolog provides insight into intracellular glycosylation.

Authors:  Carlos Martinez-Fleites; Matthew S Macauley; Yuan He; David L Shen; David J Vocadlo; Gideon J Davies
Journal:  Nat Struct Mol Biol       Date:  2008-06-08       Impact factor: 15.369

7.  Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability.

Authors:  Niall O'Donnell; Natasha E Zachara; Gerald W Hart; Jamey D Marth
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

8.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

Review 9.  Similarities in the Metabolic Reprogramming of Immune System and Endothelium.

Authors:  Chu-Yik Tang; Claudio Mauro
Journal:  Front Immunol       Date:  2017-07-21       Impact factor: 7.561

10.  O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.

Authors:  P Freund; M A Kerenyi; M Hager; T Wagner; B Wingelhofer; H T T Pham; M Elabd; X Han; P Valent; F Gouilleux; V Sexl; O H Krämer; B Groner; R Moriggl
Journal:  Leukemia       Date:  2017-01-11       Impact factor: 11.528

View more
  11 in total

Review 1.  Molecular Interrogation to Crack the Case of O-GlcNAc.

Authors:  Arielis Estevez; Dongsheng Zhu; Connor Blankenship; Jiaoyang Jiang
Journal:  Chemistry       Date:  2020-07-20       Impact factor: 5.236

Review 2.  Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.

Authors:  Amy R Nelson
Journal:  Front Aging Neurosci       Date:  2022-04-18       Impact factor: 5.702

3.  Inhibition of O-GlcNAcylation Decreases the Cytotoxic Function of Natural Killer Cells.

Authors:  Daniel Feinberg; Parameswaran Ramakrishnan; Derek P Wong; Abhishek Asthana; Reshmi Parameswaran
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

Review 4.  Glycolysis - a key player in the inflammatory response.

Authors:  Gonzalo Soto-Heredero; Manuel M Gómez de Las Heras; Enrique Gabandé-Rodríguez; Jorge Oller; María Mittelbrunn
Journal:  FEBS J       Date:  2020-04-27       Impact factor: 5.542

Review 5.  Hyperglycemia-Induced Aberrant Cell Proliferation; A Metabolic Challenge Mediated by Protein O-GlcNAc Modification.

Authors:  Tamás Nagy; Viktória Fisi; Dorottya Frank; Emese Kátai; Zsófia Nagy; Attila Miseta
Journal:  Cells       Date:  2019-08-28       Impact factor: 6.600

Review 6.  The Beginner's Guide to O-GlcNAc: From Nutrient Sensitive Pathway Regulation to Its Impact on the Immune System.

Authors:  Michael P Mannino; Gerald W Hart
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

7.  Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153.

Authors:  Yi-Nan Li; Chih-Wei Chen; Thuong Trinh-Minh; Honglin Zhu; Alexandru-Emil Matei; Andrea-Hermina Györfi; Frederic Kuwert; Philipp Hubel; Xiao Ding; Cuong Tran Manh; Xiaohan Xu; Christoph Liebel; Vladyslav Fedorchenko; Ruifang Liang; Kaiyue Huang; Jens Pfannstiel; Min-Chuan Huang; Neng-Yu Lin; Andreas Ramming; Georg Schett; Jörg H W Distler
Journal:  Bone Res       Date:  2022-07-26       Impact factor: 13.362

Review 8.  Improving Immunotherapy Through Glycodesign.

Authors:  Matthew J Buettner; Sagar R Shah; Christopher T Saeui; Ryan Ariss; Kevin J Yarema
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561

9.  Inhibition of O-GlcNAc Transferase Alters the Differentiation and Maturation Process of Human Monocyte Derived Dendritic Cells.

Authors:  Matjaž Weiss; Marko Anderluh; Martina Gobec
Journal:  Cells       Date:  2021-11-26       Impact factor: 6.600

Review 10.  Regulation and repurposing of nutrient sensing and autophagy in innate immunity.

Authors:  Julia Sanchez-Garrido; Avinash R Shenoy
Journal:  Autophagy       Date:  2020-07-05       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.